Skip to main content

Closed

IPSC: Century Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-36.9%

Financially safe

Stretched

Debt / equity0.18×

Interest coverage0.0×

Current ratio10.25×

Century Therapeutics, Inc.

IPSCNASDAQ Global Select·USD·Closed

Century Therapeutics, Inc.

IPSCNASDAQ·USD·Closed

$2.02

−7.76%

$2.02

−$0.17 (7.76%)

52W Range

61thpctl

Volume

0.35×avg

Mkt Cap

174.87MUSD

P/E

-1.6TTM

Div Yield

–ann

52W Range

61thpctl

Volume

0.35×avg

Market Cap

174.87MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings